Your browser doesn't support javascript.
loading
A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol.
Hofman, Michael S; Murphy, Declan G; Williams, Scott G; Nzenza, Tatenda; Herschtal, Alan; Lourenco, Richard De Abreu; Bailey, Dale L; Budd, Ray; Hicks, Rodney J; Francis, Roslyn J; Lawrentschuk, Nathan.
Afiliação
  • Hofman MS; Genitourinary Oncology Tumour Multidisciplinary Team, Departments of Cancer Imaging, Cancer Surgery and Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.
  • Murphy DG; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Vic., Australia.
  • Williams SG; Genitourinary Oncology Tumour Multidisciplinary Team, Departments of Cancer Imaging, Cancer Surgery and Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.
  • Nzenza T; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Vic., Australia.
  • Herschtal A; Genitourinary Oncology Tumour Multidisciplinary Team, Departments of Cancer Imaging, Cancer Surgery and Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.
  • Lourenco RA; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Vic., Australia.
  • Bailey DL; Genitourinary Oncology Tumour Multidisciplinary Team, Departments of Cancer Imaging, Cancer Surgery and Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.
  • Budd R; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Vic., Australia.
  • Hicks RJ; Olivia Newton John Cancer Research Institute, Austin Health, Melbourne, Vic., Australia.
  • Francis RJ; Centre for Biostatistics and Clinical Trials (BaCT), Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.
  • Lawrentschuk N; Centre for Health Economics Research and Evaluation, University of Technology Sydney, Sydney, NSW, Australia.
BJU Int ; 122(5): 783-793, 2018 11.
Article em En | MEDLINE | ID: mdl-29726071
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Meios de Contraste / Compostos Radiofarmacêuticos / Glutamato Carboxipeptidase II / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada / Radioisótopos de Gálio / Antígenos de Superfície Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Meios de Contraste / Compostos Radiofarmacêuticos / Glutamato Carboxipeptidase II / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada / Radioisótopos de Gálio / Antígenos de Superfície Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article